Entry Author Date Location
Five Questions With a16z’s Vijay Pande on AI and Making New Drugs 11/25/19 National
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M 11/21/19 Boston
Alnylam Gets Quick FDA OK for Second RNAi Rare Disease Drug 11/20/19 Boston
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow 11/20/19 San Francisco
Biopharma Execs Remain Optimistic Despite Political Headwinds 11/20/19 National
France-Based Tissium Boosts US Work After Closing €38.75M Series B 11/20/19 Boston
Myovant to Seek FDA OK on Pill to Treat Advanced Prostate Cancer 11/19/19 San Francisco
Reata Rakes In $505M to Advance Development of Two Rare Disease Drugs 11/19/19 National
Novo Ventures Commits $25M to Grow Discovery “Greenhouse” in Boston 11/19/19 Boston
With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite 11/18/19 New York
Underdog Launches With $4M to Target “Toxic” Form of Cholesterol 11/18/19 San Francisco
Alkermes Eyes Brain Disorders and Beyond With $100M Deal for Rodin 11/18/19 Boston
ResTORbio’s Respiratory Drug Flunks Phase 3 Test, Shattering Shares 11/15/19 Boston
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio 11/15/19 San Diego
Startup X-37 Raises $14.5M to Expand on AI-Powered Drug Discovery 11/14/19 San Francisco
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology 11/14/19 Boston
Calporta, Started by Avalon Ventures-GSK, Is Acquired by Merck 11/13/19 San Diego
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs 11/13/19 San Diego
Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing 11/12/19 Texas
FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial 11/12/19 Boston
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study 11/11/19 National
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange 11/11/19 San Francisco
Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate 11/08/19 National
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval 11/08/19 New York
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test 11/07/19 Boston
Arkuda Unveils $44M and a Protein Restoration Approach to Dementia 11/07/19 Boston
Page 2 of 293 « previous page · next page »